# 0.01% and 0.025% Atropine Eye Drops Combined Auricular Acupoint Stimulation on Myopia Control and Corneal Endothelium Change

> **NCT07537166** · NA · ENROLLING_BY_INVITATION · sponsor: **China Medical University Hospital** · enrollment: 420 (estimated)

## Conditions studied

- Acupressure

## Interventions

- **OTHER:** Auricular acupoint stimulation
- **DRUG:** 0.01% concentration atropine drops
- **DRUG:** 0.025% atropine eye drops
- **OTHER:** Artificial Tears (AT)

## Key facts

- **NCT ID:** NCT07537166
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-02-27
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537166, "0.01% and 0.025% Atropine Eye Drops Combined Auricular Acupoint Stimulation on Myopia Control and Corneal Endothelium Change". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07537166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*